机器人辅助根治性前列腺切除术后盆腔引流管的作用与尿道导管拔除时机:系统综述与Meta分析
该系统综述与Meta分析检索截至2022年3月的多个数据库,纳入8项研究共5112例患者分析盆腔引流管放置,6项研究共2598例患者分析早期拔除尿道导管(术后2-4天)。常规盆腔引流管放置未降低任何并发症、严重并发症或淋巴囊肿发生率,但避免放置可降低术后肠梗阻发生率;早期拔除尿道导管在回顾性研究中增加尿潴留风险,对中期控尿影响尚不明确。
要点
- 标准机器人辅助根治性前列腺切除术后常规放置盆腔引流管无获益。
- 避免盆腔引流管放置与术后肠梗阻发生率降低相关(合并OR 0.70,95%CI 0.51-0.91)。
- 早期拔除尿道导管在回顾性研究中增加尿潴留风险(OR 6.21,95%CI 3.54-10.9),对中期控尿影响尚不明确。
核心结论
- 已发表文献显示标准机器人辅助根治性前列腺切除术后常规放置盆腔引流管无获益。
- 早期拔除尿道导管似乎可行,但需注意尿潴留风险增加,对中期控尿的影响仍不明确。
- 这些数据可能有助于通过避免不必要干预来指导术后流程标准化,从而减少潜在并发症和相关费用。
研究设计与样本
- 系统综述与Meta分析,按照PRISMA声明检索截至2022年3月发表的多个数据库文献。
- 纳入标准为比较常规放置与不放置盆腔引流管、以及早期拔除(术后2-4天)与不早期拔除尿道导管患者术后并发症差异的研究。
- 盆腔引流管分析纳入8项研究共5112例患者,尿道导管拔除分析纳入6项研究共2598例患者。
主要发现
- 常规放置与不放置盆腔引流管患者任何并发症发生率无差异(合并OR 0.89,95%CI 0.78-1.00)。
- 常规放置与不放置盆腔引流管患者严重并发症(Clavien-Dindo分级≥III级)发生率无差异(合并OR 0.95,95%CI 0.54-1.69)。
- 常规放置与不放置盆腔引流管患者全部淋巴囊肿(合并OR 0.82,95%CI 0.50-1.33)和/或症状性淋巴囊肿(合并OR 0.58,95%CI 0.26-1.29)发生率无差异。
- 避免放置盆腔引流管降低术后肠梗阻发生率(合并OR 0.70,95%CI 0.51-0.91)。
- 早期拔除尿道导管在回顾性研究中增加尿潴留风险(OR 6.21,95%CI 3.54-10.9),但在前瞻性研究中未增加。
临床怎么用
- 已发表文献显示标准机器人辅助根治性前列腺切除术后常规放置盆腔引流管无获益。
- 早期拔除尿道导管似乎可行,但需注意尿潴留风险增加,对中期控尿的影响仍不明确。
局限性
- 早期拔除尿道导管增加尿潴留风险的结论仅见于回顾性研究,前瞻性研究中未观察到。
- 早期拔除尿道导管对中期控尿的影响仍不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the clinical value of routine pelvic drain (PD) placement and early removal of urethral catheter (UC) in patients undergoing robot-assisted radical prostatectomy (RARP), as perioperative management such as the necessity of PD or optimal timing for UC removal remains highly variable. METHODS: Multiple databases were searched for articles published before March 2022 according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Studies were deemed eligible if they investigated the differential rate of postoperative complications between patients with/without routine PD placement and with/without early UC removal, defined as UC removal at 2-4 days after RARP. RESULTS: Overall, eight studies comprising 5112 patients were eligible for the analysis of PD placement, and six studies comprising 2598 patients were eligible for the analysis of UC removal. There were no differences in the rate of any complications (pooled odds ratio [OR] 0.89, 95% confidence interval [CI] 0.78-1.00), severe complications (Clavien-Dindo Grade ≥III; pooled OR 0.95, 95% CI 0.54-1.69), all and/or symptomatic lymphocele (pooled OR 0.82, 95% CI 0.50-1.33; and pooled OR 0.58, 95% CI 0.26-1.29, respectively) between patients with or without routine PD placement. Furthermore, avoiding PD placement decreased the rate of postoperative ileus (pooled OR 0.70, 95% CI 0.51-0.91). Early removal of UC resulted in an increased likelihood of urinary retention (OR 6.21, 95% CI 3.54-10.9) in retrospective, but not in prospective studies. There were no differences in anastomosis leakage and early continence rates between patients with or those without early removal of UC. CONCLUSIONS: There is no benefit for routine PD placement after standard RARP in the published articles. Early removal of UC seems possible with the caveat of the increased risk of urinary retention, while the effect on medium-term continence is still unclear. These data may help guide the standardisation of postoperative procedures by avoiding unnecessary interventions, thereby reducing potential complications and associated costs.
引用
- Yanagisawa T, Kawada T, Mostafaei H, et al. Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis. BJU Int. 2023. PMID: 37014288. doi:10.1111/bju.16022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。